|
10112
|
Imovax Rabies(Pre exposure)
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
2005
|
France
|
All age group
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
WISTAR Rabies PM/WI38-1503-3M strain
|
Human diploid cell vaccine
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/imovax
|
|
10113
|
Imovax Rabies(Post exposure)
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
2005
|
France
|
All age group
|
5 doses on day 0, 3, 7, 14 and 28
|
Intramuscular
|
NA
|
WISTAR Rabies PM/WI38-1503-3M strain
|
Human diploid cell vaccine
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/imovax
|
|
10114
|
RabAvert
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Novartis
|
NA
|
NA
|
All age group
|
4 doses on day 0, 3, 7 and 14
|
Intramuscular
|
NA
|
NA
|
Purified chick embryo cell
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.fda.gov/files/vaccines%2C%20blood%20&%20biologics/published/Package-Insert---RabAvert.pdf
|
|
10115
|
Imogam Rabies-HT
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
NA
|
NA
|
All age group
|
4 doses on day 0, 7 and 21 or 28
|
Intramuscular
|
NA
|
NA
|
Rabies Immunoglobin
|
Government of Canada
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.sanofi.ca/dam/jcr:21c480e0-afcd-4a38-bfee-fb9b7a6b21e0/imogam-rabies-pasteurized.pdf
|
|
10116
|
HyperRabTM S/D
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Talecris Biotherapeutics Bayer Biological Products
|
NA
|
NA
|
NA
|
NA
|
Intramuscular
|
NA
|
NA
|
Rabies Immunoglobin
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.hyperrab.com/en/hcp
|
|
10117
|
Verorab
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
2015
|
France
|
NA
|
5 doses on day 0, 3, 7, 14 and 28
|
Intramuscular
|
NA
|
WISTAR Rabies PM/WI38-1503-3M strain
|
Purified vero cell rabies vaccine
|
DCGI
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://ncdc.gov.in/WriteReadData/l892s/File557.pdf
|
|
10118
|
Lyssavac N
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Zydus Candila Healthcare Limited
|
NA
|
India
|
NA
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
NA
|
Purified duck embryo cell
|
WHO
|
Berna Biotech
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.moph.go.th/sites/drug/Summary/1C_278_50_Lyssavac%20N%20Injection.pdf
|
https://www.livemint.com/Companies/XopdfNnBp4Y6189QY3PY2N/Zydus-Cadila-receives-WHO-nod-for-rabies-vaccine.html
|
|
10119
|
Rabipur
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
GlaxoSmithKline
|
NA
|
NA
|
All age group
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
NA
|
Purified chick embryo cell
|
DCGI
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/vaccines/vpd/rabies/hcp/index.html#ref
|
https://www.wbhealth.gov.in/uploaded_files/IDSP/Guideline_Rabies_prophylaxis_PPT_PDF.pdf
|
|
10120
|
Rabivax-S
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Ross University School of Veterinary Medicine
|
2019
|
India
|
All age group
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
NA
|
Human diploid cell vaccine
|
DCGI
|
Serum Institute of India
|
NA
|
NA
|
NA
|
NCT03741270
|
https://clinicaltrials.gov/ct2/show/NCT03741270
|
http://test.pharmabiz.com/news/serum-institute-launches-rabies-vaccine-rabivax-24382
|
|
10121
|
KAMRAB-003
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Live-attenuated
|
Approved
|
Kamada Ltd.
|
2014
|
USA
|
18 - 75 years
|
5 doses on day 0, 3, 7, 14 and 28
|
Intramuscular
|
NA
|
NA
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NCT02040090
|
https://clinicaltrials.gov/ct2/show/NCT02040090?cond=Rabies+Human&phase=23&draw=2&rank=5
|
https://pdf.hres.ca/dpd_pm/00048173.PDF
|
|
10122
|
Speeda
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Beijing Center for Disease Control and Prevention
|
2013
|
China
|
NA
|
3 doses on day 0, 7 and 21
|
Intramuscular
|
NA
|
NA
|
NA
|
Thailand FDA
|
NA
|
NA
|
NA
|
NA
|
NCT01821911
|
https://clinicaltrials.gov/ct2/show/NCT01821911?cond=Rabies+Human&phase=23&draw=2&rank=7
|
https://www.immunize.org/askexperts/experts_rab.asp
|
|
10369
|
SYN023 (Freeze-dried Rabies Vaccine for Human Use (Vero Cells))
|
Rabies
|
Neurologic
|
Rabies virus
|
negative-sense, single-stranded RNA
|
NA
|
Phase 3
|
Synermore Biologics (Suzhou) Co. Ltd.
|
2020
|
China
|
18 years and above
|
5 doses on day 1, 4, 8, 15 and 29
|
Intramuscular
|
NA
|
NA
|
NA
|
US FDA
|
Simoon Record Pharma Information Consulting Co. Ltd., Clinchoice Inc.
|
NA
|
NA
|
NA
|
NCT04644484
|
https://clinicaltrials.gov/ct2/show/NCT04644484?cond=Rabies+Human&phase=23&draw=2&rank=4
|
NA
|